This invention relates to devices and methods for providing drug delivery to breached tissue surrounding trocars during surgery.
Trocars are currently used during laparoscopic surgery to provide entry points for surgical instruments and surgical materials into the patient abdomen. Often, these entry points become sources of post-operative pain due to the incision and forces applied at the incision during surgery. In fact for most patients, the primary source of pain after surgery is pain at the incision site. Sometimes the pain is treated with opioids or other pain medication that may lead to addiction and other medical issues. Alternatively, some hospitals are utilizing medications such as Pivacain (Bupivacaine Hydrochloride), Exparel, etc. as local anesthetics injected around the trocar incisions before, during and after surgery to minimize post-operative pain.
The concepts described herein are intended to facilitate the controlled delivery of such anesthetics and/or other medications (i.e. clotting agents, growth-aiding agents, infection-fighting agents, etc), via the trocar and/or attachments to the trocar.
There are several delivery mechanisms available for delivering medications such as Pivacain (or other medications) at the site of a trocar. For the purposes of this disclosure, it is assumed that the medication will either be packaged with the trocar or the trocar attachment, or will be applied to the trocar or trocar attachment at the time of use. For packaging with the trocar or trocar attachment, the medication may be contained in a reservoir or integrated with another polymer or substance that may facilitate a timed release.
In either case, packaged with the device or applied at the time of use, the medication may be introduced directly through the trocar itself (via the CO2 line, for example), through a reservoir built into the trocar, or through a reservoir that attaches to the trocar, externally. For the purposes of this document, a reservoir may consist of a volume containing only the medication or a volume of material that is mixed with the medication that could include plastics, polymers or other agents that modify the medication physical properties to facilitate a desired result such as a timed release. The following embodiments, which are depicted on the below chart, will describe each of these introduction methods in further detail.
The first embodiment is comprised of an external reservoir for the medication intended to be delivered and the trocar, through which the delivery is executed. The trocar can consist of one or more lumens through which surgical instrumentation, and the medication may be delivered. A single lumen example may have more than one entry and exit point along its length. The surgical instrumentation may only be able to utilize one of the entry locations and one of the exit locations, typically in line with the axis of the single lumen, but not required. The medication may utilize one or more entry points and one or more exits. The most basic example can be seen in
In
Potential Actuation Mechanisms:
The above dispensing mechanisms and reservoir locations could also be utilized in trocars having more than one lumen, where the primary lumen is utilized for surgical instrument passage and the secondary lumen(s) are intended to facilitate transfer of the medication to the target sites.
A simple example of this concept may be a tube-in-a-tube, as shown in
The third embodiment for an attachment to the trocar consists of a medication reservoir, pre-filled or filled at the time of use, that can be attached to the head of the trocar itself. For some trocars, including those from Ethicon Endosurgery (e.g. the Endopath Exel Trocar), the trocar shaft seal can be removed from the trocar shaft as a means to remove large specimen or insert sharp objects that could damage the seal. For trocars of this type, in particular, a medication reservoir may be installed between the trocar shaft and the removable housing that includes the trocar shaft seal.
In the embodiment discussed above, the delivery actuation mechanisms could also include leveraging the pressure from the CO2 pneumoperitoneum line, manual activation and/or activation via pressure applied through the surgical instrument shaft. As with the previous embodiment, the reservoir attachment could deliver the medication via the primary lumen, or through secondary lumen(s) to the target tissue.
In this embodiment, shown in
As with the previously described reservoir attachment, the integral reservoir could be pre-filled or filled at the time of use and could also utilize the same attachment mechanisms. The primary difference is that this embodiment is built directly into a custom trocar, whereas the reservoir attachment is intended for use with other off-the-shelf (OTS) trocars.
The next embodiment consists of a reservoir sleeve that is engaged with the external shaft of the trocar. The sleeve is captured between the trocar shaft and the fascial wall and may dispense medications in response to forces applied to the trocar or manually actuated by squeezing an accessible reservoir, for example. The sleeve may also include an exposed luer fitting such that additional fluid may be added during the procedure without removing the trocar. See
A final last embodiment includes a reservoir disc that is captured between the abdominal wall and the trocar head. This disc may be a compressible material, such as foam, that can be immersed or injected with the medication prior to, or during the procedure. As with other reservoirs detailed in this document, the medication may be dispensed by manual compression (i.e. force applied to the head of the trocar) or as a response to forces applied by the instrument at the trocar site. See
While the reservoir disc may not provide direct access to the breached fascial tissue, this concept will be the least expensive option to pursue in addition to being the most flexible for various trocar diameters and manufacturers. In particular the foam may be pre-slit or die-cut such that the center can be dilated with any trocar shaft. Additionally, the foam could just allow the trocar to cut its own channel through the reservoir.
Other options for delivering anesthetic agent might include delivery of nanoparticles into, or on, the tissue at the incision site in order to deliver a slower-release agent to the site, giving longer lasting relief to the patient.
This application claims priority to U.S. Provisional Application No. 62/874990, filed Jul. 17, 2019, which is fully incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62874990 | Jul 2019 | US |